ProQR Therapeutics (PRQR) Total Liabilities (2021 - 2024)
Historic Total Liabilities for ProQR Therapeutics (PRQR) over the last 4 years, with Q4 2024 value amounting to $84.8 million.
- ProQR Therapeutics' Total Liabilities fell 1827.8% to $84.8 million in Q4 2024 from the same period last year, while for Dec 2024 it was $84.8 million, marking a year-over-year decrease of 1827.8%. This contributed to the annual value of $85.9 million for FY2024, which is 1766.91% down from last year.
- According to the latest figures from Q4 2024, ProQR Therapeutics' Total Liabilities is $84.8 million, which was down 1827.8% from $103.8 million recorded in Q4 2023.
- ProQR Therapeutics' 5-year Total Liabilities high stood at $51.2 billion for Q1 2021, and its period low was $54.0 million during Q2 2021.
- For the 4-year period, ProQR Therapeutics' Total Liabilities averaged around $4.0 billion, with its median value being $103.8 million (2023).
- Examining YoY changes over the last 5 years, ProQR Therapeutics' Total Liabilities showed a top increase of 8205.81% in 2022 and a maximum decrease of 9980.26% in 2022.
- Over the past 4 years, ProQR Therapeutics' Total Liabilities (Quarter) stood at $110.2 million in 2021, then decreased by 3.14% to $106.8 million in 2022, then fell by 2.75% to $103.8 million in 2023, then fell by 18.28% to $84.8 million in 2024.
- Its Total Liabilities was $84.8 million in Q4 2024, compared to $103.8 million in Q4 2023 and $104.2 million in Q3 2023.